Pharmacotherapy|教育線上App不用買-HotApp4Game

Pharmacotherapy is the only journal that publishes comprehensive and authoritative evaluations of new drugs introduced in the US at about the time they are marketed. It also evaluates new uses for older drugs, reviews treatment of selected diseases, reassesses older drugs and examines controversial topics in drug therapy. Pharmacotherapy is now available on your iPad and iPhone. Fresh from the Newsstand, the “PHAR” app keeps you up to date with all the latest international news and peer-reviewed research.

Download the app today and enjoy a new browsing and reading experience, where you can:

• Download and read Pharmacotherapy’s most recent issues

• Be notified when a new issue is available

• Save your favorite articles for quick and easy access offline

• Browse, search and bookmark articles from all available issues

• Share links to your favorite articles with colleagues and friends

CURRENT SUBSCRIBERS to Pharmacotherapy can “pair” their device with their personal or institutional subscription to enjoy full access in this mobile edition.

SUBSCRIBE IN THE APP: Annual Subscriptions (12 issues) for the mobile-only edition are available for $199.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. Pharmacotherapy subscriptions automatically renew within 24 hours of the end of your subscription period for $199.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.

Review Notes:

Please use the Current subscribers “Learn how to get access” option on the loading screen (or other points of authentication), then “Log in” using the account details below to unlock all content.